NATUR OG BIOENERGI ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/7
2021
2021/7
2022
2022/7
2023
2023/7
2024
2024/7
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  7.9% 6.2% 6.8% 4.9% 3.6%  
Credit score (0-100)  31 37 35 43 52  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/7
2021
2021/7
2022
2022/7
2023
2023/7
2024
2024/7

Net sales  0 0 0 0 0  
Gross profit  -60.1 37.0 84.3 147 43.4  
EBITDA  -60.1 37.0 84.3 147 43.4  
EBIT  -60.1 15.5 62.8 125 43.3  
Pre-tax profit (PTP)  -65.3 -7.8 43.0 105.3 27.9  
Net earnings  -65.3 -7.8 43.0 105.3 15.8  
Pre-tax profit without non-rec. items  -65.3 -7.8 43.0 105 27.9  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/7
2021
2021/7
2022
2022/7
2023
2023/7
2024
2024/7

Tangible assets total  0.0 193 172 150 150  
Shareholders equity total  -114 -122 -78.9 26.4 42.2  
Interest-bearing liabilities  42.3 1.0 27.0 128 190  
Balance sheet total (assets)  42.4 526 268 239 266  

Net Debt  9.6 -8.9 17.6 109 138  
 
See the entire balance sheet

Volume 
2020
2020/7
2021
2021/7
2022
2022/7
2023
2023/7
2024
2024/7

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -60.1 37.0 84.3 147 43.4  
Gross profit growth  -185.6% 0.0% 127.8% 73.8% -70.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  42 526 268 239 266  
Balance sheet change%  60.7% 1,140.5% -48.9% -11.1% 11.6%  
Added value  -60.1 37.0 84.3 146.6 43.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 172 -43 -43 -0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 1.0 2.0 3.0 4.0  

Profitability 
2020
2020/7
2021
2021/7
2022
2022/7
2023
2023/7
2024
2024/7
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 41.9% 74.5% 85.3% 99.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -51.9% 3.9% 13.1% 43.3% 18.1%  
ROI %  -144.8% 71.7% 466.5% 140.0% 22.6%  
ROE %  -190.0% -2.7% 10.8% 71.4% 46.0%  

Solidity 
2020
2020/7
2021
2021/7
2022
2022/7
2023
2023/7
2024
2024/7
Equity ratio %  -72.9% -18.8% -22.7% 11.1% 15.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -16.0% -23.9% 20.8% 74.5% 318.6%  
Gearing %  -37.1% -0.8% -34.2% 483.2% 449.0%  
Net interest  0 0 0 0 0  
Financing costs %  12.6% 107.6% 158.8% 27.8% 11.2%  

Liquidity 
2020
2020/7
2021
2021/7
2022
2022/7
2023
2023/7
2024
2024/7
Quick Ratio  0.3 0.2 0.3 0.3 0.6  
Current Ratio  0.3 0.5 0.3 0.4 0.6  
Cash and cash equivalent  32.7 9.8 9.4 18.5 51.4  

Capital use efficiency 
2020
2020/7
2021
2021/7
2022
2022/7
2023
2023/7
2024
2024/7
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -114.1 -315.4 -250.8 -124.1 -90.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/7
2021
2021/7
2022
2022/7
2023
2023/7
2024
2024/7
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0